Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

BACKGROUND/AIMS: Breast cancer metastasis suppressor 1 (BRMS1) blocks metastasis in melanoma xenografts; however, its usefulness as a biomarker in human melanomas has not been widely studied. The goal was to measure BRMS1 expression in benign nevi, primary and metastatic melanomas and evaluate its i...

Descripción completa

Detalles Bibliográficos
Autores principales: Slipicevic, Ana, Holm, Ruth, Emilsen, Elisabeth, Ree Rosnes, Anne Katrine, Welch, Danny R, Mælandsmo, Gunhild M, Flørenes, Vivi Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341185/
https://www.ncbi.nlm.nih.gov/pubmed/22356677
http://dx.doi.org/10.1186/1471-2407-12-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341185/
https://www.ncbi.nlm.nih.gov/pubmed/22356677
http://dx.doi.org/10.1186/1471-2407-12-73

Ejemplares similares